Mei Pharma, Inc.8月1日成交额为169.38万美元

市场透视08-02

美东时间2025年8月1日，Mei Pharma, Inc.（MEIP.US）成交额为169.38万美元，成交额较昨日增加20.78%，当日成交量为34.95万股。Mei Pharma, Inc.（MEIP.US）于2025年8月1日跌5.44%，报4.87美元，该股过去5个交易日跌27.74%，年初至今涨97.97%，过去60日涨129.72%。|近5个交易日成交情况||||#|日期|成交额（...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2556633847?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-02 11:56","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2556633847","market":"us","top_or_hot":-1,"title":"Mei Pharma, Inc.8月1日成交额为169.38万美元","media":"市场透视","content":"<div>\n<p>美东时间2025年8月1日，Mei Pharma, Inc.（MEIP.US）成交额为169.38万美元，成交额较昨日增加20.78%，当日成交量为34.95万股。Mei Pharma, Inc.（MEIP.US）于2025年8月1日跌5.44%，报4.87美元，该股过去5个交易日跌27.74%，年初至今涨97.97%，过去60日涨129.72%。|近5个交易日成交情况||||#|日期|成交额（...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802115617a470c613&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mei Pharma, Inc.8月1日成交额为169.38万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMei Pharma, Inc.8月1日成交额为169.38万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-02 11:56 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802115617a470c613&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美东时间2025年8月1日，Mei Pharma, Inc.（MEIP.US）成交额为169.38万美元，成交额较昨日增加20.78%，当日成交量为34.95万股。Mei Pharma, Inc.（MEIP.US）于2025年8月1日跌5.44%，报4.87美元，该股过去5个交易日跌27.74%，年初至今涨97.97%，过去60日涨129.72%。|近5个交易日成交情况||||#|日期|成交额（...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802115617a470c613&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802115617a470c613&s=b","article_id":"2556633847","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802115617a470c613&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2556633847","pubTimestamp":1754106971,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"美东时间2025年8月1日，Mei Pharma, Inc.成交额为169.38万美元，成交额较昨日增加20.78%，当日成交量为34.95万股。Mei Pharma, Inc.于2025年8月1日跌5.44%，报4.87美元，该股过去5个交易日跌27.74%，年初至今涨97.97%，过去60日涨129.72%。该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技"},"translate_title":"Mei Pharma, Inc. 's turnover on August 1 was US $1,693,800","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MEIP":0.9},"content_text":"美东时间2025年8月1日，Mei Pharma, Inc.（MEIP.US）成交额为169.38万美元，成交额较昨日增加20.78%，当日成交量为34.95万股。Mei Pharma, Inc.（MEIP.US）于2025年8月1日跌5.44%，报4.87美元，该股过去5个交易日跌27.74%，年初至今涨97.97%，过去60日涨129.72%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-01|169.38万|20.78%|34.95万|#|2025-07-31|140.24万|-46.74%|27.27万|#|2025-07-30|263.32万|-54.08%|52.40万|#|2025-07-29|573.38万|-18.02%|109.16万|#|2025-07-28|699.44万|83.36%|111.98万|MEI Pharma Inc 专注于癌症新疗法的临床开发。 该公司的临床候选药物包括 Pracinostat，这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。 其临床开发产品组合还包括 Zandelisib，一种磷脂酰肌醇 3-激酶 delta 的口服抑制剂，用于治疗复发性慢性淋巴细胞白血病或滤泡性非霍奇金淋巴瘤患者； ME-344，一种基于异黄酮的线粒体抑制剂，用于治疗 HER2 阴性乳腺癌和 Pracinostat，一种口服组蛋白脱乙酰酶抑制剂。 在地理上，所有的商业活动都通过美国地区运作。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2556633847","isCrawlerRequest":true}